{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lysine-Proline-Valine)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is KPV?<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> is the Lys-Pro-Val tripeptide \u2014 the C-terminal anti-inflammatory fragment of alpha-melanocyte stimulating hormone (\u03b1-MSH). Unlike broader melanocortin analogs, KPV has <strong>no pigmentation activity<\/strong>; its research signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation research. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Wat u krijgt bij MedsBase:<\/strong> Onderzoekskwaliteit lyofiliseerde peptiden \u00b7 HPLC \u226599% zuiverheid (COA op aanvraag) \u00b7 Discrete temperatuurstabiele verpakking \u00b7 Wereldwijde peptidekoerier \u00b7 1.400+ geverifieerd <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specificatie<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molecuulformule<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Moleculair gewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd poeder (of zoals geleverd)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Zuiverheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Opslag<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd: 2\u20138 \u00b0C (koelkast) voor werkvoorraad; \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerd: 2\u20138 \u00b0C, gebruik binnen ~30 dagen. Bescherm tegen licht. Vries de gereconstitueerde oplossing niet in en ontdooi deze niet.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Oplosbaarheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatisch water (aanbevolen) of steriel water voor kortere gebruiksperioden<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Onderzoeksgebruik<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Alleen voor laboratoriumonderzoek. Niet voor humaan of veterinair diagnostisch of therapeutisch gebruik.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is KPV?<\/h2>\n<p><strong>KPV<\/strong> is the three-letter one-letter-code shorthand for the <strong>Lys-Pro-Val tripeptide<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple research groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>anti-inflammatory<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects.<\/p>\n<p>Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory research tripeptides. It is supplied as a high-purity lyophilized powder. KPV is <strong>uitsluitend voor laboratoriumonderzoek<\/strong> and is not intended for human or veterinary diagnosis or therapy. For mechanism, IBD research history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/nl\/kpv-peptide-anti-inflammatory-guide\/\">KPV research guide<\/a>.<\/p>\n<h2>Mechanism of Action \u2014 Three Anti-Inflammatory Pathways<\/h2>\n<p>KPV&#8217;s anti-inflammatory activity operates through at least three complementary pathways, all of which converge on reducing inflammatory signaling without affecting other melanocortin functions:<\/p>\n<ul>\n<li><strong>NFkB inhibition<\/strong> \u2014 KPV blocks the translocation of NFkB into the nucleus, preventing transcription of pro-inflammatory cytokines including TNF-alpha, IL-6, IL-1\u03b2, and IL-8. NFkB is the master regulator of inflammatory gene expression, so blocking its activation produces a broad, upstream anti-inflammatory effect.<\/li>\n<li><strong>Mast-cell stabilization<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in research models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation research and topical skin-inflammation models.<\/li>\n<li><strong>Peptide-vs-MSH separation<\/strong> \u2014 because KPV is only the C-terminal fragment, it <strong>does not activate MC1R<\/strong> (the pigmentation receptor) or MC4R (the arousal\/feeding receptor). This mechanistically separates the anti-inflammatory activity from \u03b1-MSH&#8217;s other effects \u2014 distinct from broader MC analogs such as <a href=\"https:\/\/medsbase.com\/nl\/melanotan-ii\/\">Melanotan II<\/a> of <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical research implication: KPV is a &#8220;clean&#8221; anti-inflammatory research tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of research using full-length MC agonists.<\/p>\n<h2>Gepubliceerde onderzoeksapplicaties<\/h2>\n<p>KPV is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis research<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation research (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>Allergic inflammation<\/strong> \u2014 mast-cell stabilization and histamine-release research in allergy and atopy models<\/li>\n<li><strong>Skin inflammation<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis research models; topical formulations appear in some research protocols<\/li>\n<li><strong>Wound healing<\/strong> \u2014 anti-inflammatory phase of wound-healing research, often paired with <a href=\"https:\/\/medsbase.com\/nl\/bpc-157\/\">BPC-157<\/a> for combined anti-inflammatory and growth-factor coverage<\/li>\n<li><strong>Joint inflammation<\/strong> \u2014 arthritis and joint-inflammation rodent research models<\/li>\n<li><strong>Stacking research<\/strong> \u2014 commonly paired with <a href=\"https:\/\/medsbase.com\/nl\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue research where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative research<\/strong> \u2014 side-by-side with <a href=\"https:\/\/medsbase.com\/nl\/melanotan-ii\/\">Melanotan II<\/a> en <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141<\/a> to isolate the pure anti-inflammatory vs MC-receptor effects<\/li>\n<\/ul>\n<p>For broader context on anti-inflammatory and healing peptides see the <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\">onderzoekspeptiden catalogus<\/a>.<\/p>\n<h2>Beschikbare sterktes en concentraties<\/h2>\n<p>MedsBase stocks KPV in the following lyophilized vial sizes:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vulsterkte<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typisch gebruik<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Verpakkingsgroottes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short research protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 of 30 vialen<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard research strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 of 30 vialen<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV research protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory research, or topical\/oral routes for GI and skin research contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity.<\/p>\n<h2>How It Compares \u2014 KPV vs Other Anti-Inflammatory \/ Melanocortin Peptides<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in research use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lengte<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino acids<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino acids<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino acids (cyclic)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary activity<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anti-inflammatory only<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anti-inflammatory + tissue repair + GH receptor<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Broad MC agonist (MC1-5)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>MC-receptor activity<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">None (C-terminal only)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Geen<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1, MC3, MC4, MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Pigmentatie-effect<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Geen<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Geen<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Strong (primary signal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Research applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">IBD, allergy, skin inflammation<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tendon, gut, muscle recovery<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Melanogenesis, photoprotection<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation research, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/nl\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 onderzoeksgids<\/a>.<\/p>\n<h2>Opslag en Reconstituering<\/h2>\n<p><strong>Voor reconstituering:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging, stable up to 36 months. Avoid freeze-thaw cycles on the powder.<\/p>\n<p><strong>Reconstitueringsprocedure:<\/strong> inject bacteriostatic water down the side wall of the peptide vial per the chart above. Swirl gently \u2014 do <strong>niet<\/strong> shake \u2014 and allow 5\u201310 minutes for full dissolution. Solution should be clear and colourless.<\/p>\n<p><strong>Na reconstitutie:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days. Do not freeze reconstituted solution.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3>What is KPV used for in research?<\/h3>\n<p>KPV is used in laboratory research investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>niet<\/strong> FDA-approved and is sold here strictly for laboratory research use only.<\/p>\n<h3>How is KPV different from Melanotan II or PT-141?<\/h3>\n<p>KPV is only the three-amino-acid C-terminal fragment of alpha-MSH, whereas Melanotan II and PT-141 are full-length or near-full cyclic MSH analogs. This means KPV has <strong>no melanocortin-receptor activity<\/strong> and therefore no pigmentation (MC1R), arousal (MC4R), or appetite (MC4R) effects \u2014 only anti-inflammatory activity via NFkB and mast-cell pathways.<\/p>\n<h3>What is the typical KPV research dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory research. Some IBD and skin-inflammation research uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg.<\/p>\n<h3>Is KPV FDA approved?<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related research has informed melanocortin drug development broadly, but KPV itself remains research-use-only. All KPV sold by peptide-research suppliers is for laboratory investigation only.<\/p>\n<h3>Can KPV be taken orally for IBD research?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis research. This makes it unusually flexible for GI-inflammation research where oral delivery targets the GI tract directly. Research protocols vary by model \u2014 SC remains the dominant systemic route.<\/p>\n<h3>How should KPV be stored?<\/h3>\n<p>Lyophilized vials: refrigerated at 2\u20138\u00a0\u00b0C in original packaging, stable up to 36 months. Reconstituted solution: refrigerated at 2\u20138\u00a0\u00b0C, use within 30 days. Do not freeze reconstituted solution.<\/p>\n<h3>How do I reconstitute KPV?<\/h3>\n<p>Follow the reconstitution chart above. Add bacteriostatic water down the side wall of the vial, swirl gently, and allow 5\u201310 minutes for full dissolution. Do <strong>niet<\/strong> schudden.<\/p>\n<h3>Can KPV and BPC-157 be stacked in research?<\/h3>\n<p>Yes \u2014 this is one of the most common research combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/nl\/bpc-157\/\">BPC-157<\/a> provides VEGF-pathway tissue-repair and growth-factor activity. The mechanisms are complementary rather than overlapping.<\/p>\n<h3>Welke sterktes heeft MedsBase op voorraad?<\/h3>\n<p>MedsBase carries KPV in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request.<\/p>\n<h3>Does KPV cause side effects in research?<\/h3>\n<p>Published preclinical research has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical research doses. Long-term human safety data are not available.<\/p>\n<h3>What is the half-life of KPV?<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary research application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa.<\/p>\n<h3>How does KPV reduce inflammation in research models?<\/h3>\n<p>KPV is the C-terminal tripeptide of \u03b1-MSH (alpha-melanocyte stimulating hormone) and retains much of the parent peptide&#8217;s anti-inflammatory activity via MC1R activation. In colitis and gut injury models, KPV reduces NF-\u03baB signalling, decreases pro-inflammatory cytokine production (IL-1\u03b2, IL-6, TNF-\u03b1), and promotes intestinal epithelial barrier integrity. Its small size facilitates direct epithelial cell uptake independent of carrier proteins.<\/p>\n<h3>Can I order KPV for international shipping?<\/h3>\n<p>Yes. MedsBase ships KPV worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. Orders ship in temperature-controlled packaging with full tracking.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Andere Peptiden voor Herstel- en Prestatieonderzoek<\/h2>\n<ul>\n<li><a href=\"\/nl\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 onderzoek naar pees-, ligament- en darmherstel<\/li>\n<li><a href=\"\/nl\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosine Beta-4 fragment \u2014 onderzoek naar zacht weefsel en vasculair herstel<\/li>\n<li><a href=\"\/nl\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selectieve ghreline-agonist \u2014 schone GH-puls zonder cortisol\/prolactine<\/li>\n<li><a href=\"\/nl\/cjc-1295-with-dac\/\"><strong>CJC-1295 met DAC<\/strong><\/a> \u2014 GHRH-analoog met verlengde halfwaardetijd<\/li>\n<li><a href=\"\/nl\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Koperpeptide \u2014 onderzoek naar huid- en bindweefselregeneratie<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Verder lezen<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Lees het onderzoek achter dit peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lees onze volledige evidence-based gids: <a href=\"https:\/\/medsbase.com\/nl\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory research<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD research history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Supports tissue repair<br \/>\n\u2705 Reduces oxidative stress<br \/>\n\u2705 Modulates immune response<br \/>\n\u2705 Promotes cellular resilience<br \/>\n\u2705 Enhances epithelial integrity<\/p>\n<p><strong>KPV<\/strong> bevat synthetisch peptideverbinding.<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":{"0":"post-69013","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-kpv","8":"product_tag-lysine-proline-valine","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}